Axon Enterprise Inc. reported its Q1 2025 financial results, showing strong performance with a revenue of $604 million, marking a 31% increase year over year. This growth continues Axon's trend of exceeding 25% growth for 13 consecutive quarters. The company's net income for the quarter was $88 million, with a net income margin of 14.6%. Additionally, Axon reported a non-GAAP net income of $115 million, equating to $1.41 per diluted share, and an Adjusted EBITDA of $155 million, representing a 25.7% margin and a 42% year-over-year increase. A significant highlight was the 39% growth in Software & Services revenue, reaching $263 million, while annual recurring revenue increased by 34% to $1.1 billion. Personal Sensors revenue also saw a 30% increase, totaling $88 million, driven by the Axon Body 4 product. The newly introduced Platform Solutions category generated $57 million in revenue, growing 51% year over year, primarily due to demand for VR training and counter drone equipment. Axon also improved its financial outlook for the full year 2025, raising expected revenue to a range between $2.60 billion and $2.70 billion, up from the previous range of $2.55 billion to $2.65 billion. The company targets an Adjusted EBITDA margin of approximately 25%, or $650 million to $675 million, which is an increase from the earlier outlook of $640 million to $670 million. As of March 31, 2025, Axon held $2.2 billion in cash, cash equivalents, and investments, with a net cash position of $171 million, reflecting a $61 million increase sequentially.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.